December 11, 2020
Megatrends Meet COVID-19 – Bio Pharma Business, Medical and Regulatory Perspectives
During the 15th Annual Healthcare Industry Leadership Virtual Conference, A&M experts discussed how COVID-19 has propelled the biotech and pharmaceutical industry – vaccine production, research and innovation and opportunities for investment – tenfold in just a few short months.
In this session, the panelists also discussed:
- Near- and long-term industry outlook
- Expanded patient access for clinical trials
- Developing regulatory challenges
- Emerging players and platforms
- Expanding role for telehealth
Panel Moderator:
Dr. Keith Ghezzi, Managing Director, A&M Healthcare Industry Group
Speakers:
Jacques Mulder, former Managing Director, A&M Healthcare Industry Group
Peter Urbanowicz, Managing Director and Co-Head of A&M's Healthcare Industry Group
Watch the other panel sessions here:
Healthcare Systems in the COVID-19 Era
Diversity & Inclusion in Healthcare Organizations